| # | Title | Journal | Year | Citations |
|---|
| 1 | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | American Journal of Kidney Diseases | 2002 | 7,042 |
| 2 | Leptin and renal disease | American Journal of Kidney Diseases | 2002 | 6,157 |
| 3 | Revised Equations for Estimated GFR From Serum Creatinine in Japan | American Journal of Kidney Diseases | 2009 | 5,260 |
| 4 | Clinical epidemiology of cardiovascular disease in chronic renal disease | American Journal of Kidney Diseases | 1998 | 2,995 |
| 5 | Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey | American Journal of Kidney Diseases | 2003 | 2,193 |
| 6 | Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study | American Journal of Kidney Diseases | 1998 | 2,149 |
| 7 | Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between Facilities | American Journal of Kidney Diseases | 1990 | 1,871 |
| 8 | Hospital-acquired renal insufficiency | American Journal of Kidney Diseases | 2002 | 1,676 |
| 9 | K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease | American Journal of Kidney Diseases | 2003 | 1,637 |
| 10 | Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis | American Journal of Kidney Diseases | 2009 | 1,612 |
| 11 | Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis | American Journal of Kidney Diseases | 2002 | 1,435 |
| 12 | Preserving renal function in adults with hypertension and diabetes: A consensus approach | American Journal of Kidney Diseases | 2000 | 1,314 |
| 13 | KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease | American Journal of Kidney Diseases | 2007 | 1,298 |
| 14 | 2002 annual report: ESRD clinical performance measures project | American Journal of Kidney Diseases | 2003 | 1,266 |
| 15 | KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD | American Journal of Kidney Diseases | 2014 | 1,249 |
| 16 | KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update | American Journal of Kidney Diseases | 2012 | 1,095 |
| 17 | KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update | American Journal of Kidney Diseases | 2020 | 1,087 |
| 18 | III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000 | American Journal of Kidney Diseases | 2001 | 1,083 |
| 19 | Bone metabolism and disease in chronic kidney disease | American Journal of Kidney Diseases | 2003 | 1,067 |
| 20 | Goodpasture syndrome during the course of a Schönlein-Henoch purpura | American Journal of Kidney Diseases | 2002 | 1,060 |
| 21 | Clinical Practice Guidelines for Vascular Access | American Journal of Kidney Diseases | 2006 | 1,010 |
| 22 | Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD | American Journal of Kidney Diseases | 2008 | 944 |
| 23 | Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis | American Journal of Kidney Diseases | 2009 | 933 |
| 24 | Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage | American Journal of Kidney Diseases | 1992 | 924 |
| 25 | Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS) | American Journal of Kidney Diseases | 2008 | 888 |
| 26 | Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease | American Journal of Kidney Diseases | 1998 | 856 |
| 27 | KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update | American Journal of Kidney Diseases | 2020 | 829 |
| 28 | Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences | American Journal of Kidney Diseases | 2003 | 823 |
| 29 | KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update | American Journal of Kidney Diseases | 2015 | 822 |
| 30 | K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients | American Journal of Kidney Diseases | 2005 | 814 |
| 31 | K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease | American Journal of Kidney Diseases | 2004 | 793 |
| 32 | C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients | American Journal of Kidney Diseases | 2000 | 792 |
| 33 | A Malnutrition-Inflammation Score is correlated with morbidity and mortality in maintenance hemodialysis patients | American Journal of Kidney Diseases | 2001 | 775 |
| 34 | Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions | American Journal of Kidney Diseases | 2010 | 773 |
| 35 | Hypernatremia in the Critically Ill Is an Independent Risk Factor for Mortality | American Journal of Kidney Diseases | 2007 | 761 |
| 36 | Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin | American Journal of Kidney Diseases | 1999 | 756 |
| 37 | Executive Summary | American Journal of Kidney Diseases | 2006 | 729 |
| 38 | Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients | American Journal of Kidney Diseases | 1996 | 723 |
| 39 | US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States | American Journal of Kidney Diseases | 2017 | 716 |
| 40 | End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions | American Journal of Kidney Diseases | 1999 | 703 |
| 41 | Use of Allopurinol in Slowing the Progression of Renal Disease Through Its Ability to Lower Serum Uric Acid Level | American Journal of Kidney Diseases | 2006 | 703 |
| 42 | The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease | American Journal of Kidney Diseases | 1996 | 699 |
| 43 | USRDS: the United States Renal Data System | American Journal of Kidney Diseases | 2003 | 695 |
| 44 | Introduction: National Kidney Foundation 50th anniversary commemorative issue | American Journal of Kidney Diseases | 2000 | 692 |
| 45 | US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States | American Journal of Kidney Diseases | 2019 | 680 |
| 46 | Antihypertensive Therapy in the Presence of Proteinuria | American Journal of Kidney Diseases | 2007 | 671 |
| 47 | Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate | American Journal of Kidney Diseases | 2002 | 667 |
| 48 | Pathologic classification of focal segmental glomerulosclerosis: a working proposal | American Journal of Kidney Diseases | 2004 | 654 |
| 49 | Clinical Practice Guidelines for Vascular Access | American Journal of Kidney Diseases | 2006 | 651 |
| 50 | Hemodialysis Membrane With a High-Molecular-Weight Cutoff and Cytokine Levels in Sepsis Complicated by Acute Renal Failure: A Phase 1 Randomized Trial | American Journal of Kidney Diseases | 2007 | 639 |
